# A Study of Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer

> **NCT01851746** · — · UNKNOWN · sponsor: **Wuhan University** · enrollment: 200 (estimated)

## Conditions studied

- Recurrent Ovarian Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01851746
- **Lead sponsor:** Wuhan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2013-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01851746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01851746, "A Study of Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01851746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*